Joseph A. Sparano, MD [clinicaltrials_resource:c9d777df935ccffbd61f6d8f2ae02476]
Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy [clinicaltrials:NCT00003010]Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes [clinicaltrials:NCT00004125]clinicaltrials:NCT00324415Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy [clinicaltrials:NCT00897299]
overall official [clinicaltrials_vocabulary:overall-official]
Joseph A. Sparano, MD [clinicaltrials_resource:c9d777df935ccffbd61f6d8f2ae02476]
Bio2RDF identifier
c9d777df935ccffbd61f6d8f2ae02476
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c9d777df935ccffbd61f6d8f2ae02476
affiliation [clinicaltrials_vocabulary:affiliation]
last name [clinicaltrials_vocabulary:last-name]
Joseph A. Sparano, MD
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:c9d777df935ccffbd61f6d8f2ae02476
title
Joseph A. Sparano, MD
@en
type
label
Joseph A. Sparano, MD [clinicaltrials_resource:c9d777df935ccffbd61f6d8f2ae02476]
@en